Visible changes & health services · guide with sources

At-Home STI Tests for Women: What They Test, How Accurate They Are, and Which Sample You Need

Compare home STI testing with mail-in collection, check which infections and body sites a kit covers, and understand results, follow-up, and costs.

Start with the infections and body sites that need testing

An at-home sexually transmitted infection test can be useful, but no single kit answers every sexual-health question. Compare the infections it detects, the body site it samples, who it is intended for, and what happens after the result. CDC distinguishes testing done entirely at home from collecting a sample at home and sending it to a laboratory. Which tests you need depends on factors such as symptoms, sexual practices, exposure, and medical history. 1

A vaginal sample is not a throat or rectal sample. Someone concerned about infection after oral or anal sex may need different testing even if a vaginal result is negative. Discuss those exposures rather than assuming that a product labeled “for women” covers every relevant site. 1

This U.S.-focused comparison was checked on September 14, 2026. The examples below illustrate FDA-authorized testing models; they are not an exhaustive market list, a stock check, or a ranking of the best products.

Two different meanings of “at home”

A device that produces results at home

FDA authorized the Visby Medical Women's Sexual Health Test in March 2025. It uses a self-collected vaginal swab to test for chlamydia, gonorrhea, and trichomoniasis, with results available in about 30 minutes through an app connected to the single-use device. The authorization covers over-the-counter use by females with or without symptoms. 2

The practical distinction is that the sample is analyzed in the home device rather than mailed to a laboratory. Before purchasing, check the current instructions, phone and app requirements, intended population, and access to follow-up care. FDA authorization does not establish that a particular retailer has the product in stock today. 2

A collection kit sent to a laboratory

FDA authorized the LetsGetChecked Simple 2 home-collection system in November 2023 for adults aged 18 and older. It tests for chlamydia and gonorrhea, using the vaginal-swab or urine kit specified for the intended user and sample. Users activate the kit online, complete a health questionnaire, and send the sample to the designated laboratory; results are delivered online, with healthcare-provider follow-up for positive or invalid results. 3

With a mail-in kit, your sample moves through collection, shipping, laboratory processing, and notification before the result is ready. The authorization ties the collection system to a specific cleared laboratory assay. It is not permission to combine any swab, mailing tube, and commercial testing panel. 3

The difference between these examples is not merely speed: one includes trichomoniasis and the other does not. Compare the actual target list, not a broad phrase such as “sexual health panel.” 2 3

Choose a panel that matches the infections and body sites you need to test

Write down what you need to know before comparing packages. Does the kit test for the infection you are concerned about? Does it use the appropriate sample? Does the intended-use information match your circumstances? CDC's testing guidance includes blood, urine, vaginal, throat, and rectal samples, depending on the question. 1

These STI panels check for specific infections. Vaginal itching can also come from yeast, bacterial vaginosis, irritation, or a vulvar skin condition, so the panel answers only part of the question. A negative result applies only to the infections tested and the conditions of the test. It does not mean every possible cause has been ruled out. 1 2 3

For the clinical comparison, see yeast infection versus STI symptoms. For the specimen question, see why vaginal, urine, throat, and rectal samples are not interchangeable.

Questions worth answering before payment

Use the product label and service terms to answer four questions:

  • What exactly is included? List the infections, sample site, kit type, and whether the price includes laboratory processing.
  • What does the quoted timing measure? Device run time, delivery time, and processing after sample arrival are not the same promise.
  • Who handles an invalid or positive result? Ask about replacement samples, clinical contact, treatment or referral, and any additional charge.
  • Who holds the record? Identify the testing service, performing laboratory where applicable, and results app or portal.

Keep in mind that testing packages, specimen types, and lab partnerships vary by provider. FDA advises reading the instructions, understanding what a home test can and cannot do, and checking storage and expiration requirements. 4 The Simple 2 and Visby examples demonstrate why workflow and follow-up must be checked separately for each product. 2 3

The laboratory-credentials guide explains what a laboratory certificate can tell you. The privacy guide addresses records and app data.

What to do with the result

A positive finding needs appropriate medical follow-up rather than a self-selected treatment. If you receive an invalid result, follow the product's instructions or contact its clinical support service. FDA's authorizations describe follow-up and acknowledge that incorrect results remain possible. 2 3

A negative result may still leave an important question unresolved, particularly when symptoms, a recent exposure, or another concern remains. FDA specifically advises additional medical assessment in that situation for the Visby test. Talk with your doctor about the timing of any possible exposure; different infections have different window periods before a test can detect them. 1 2

Do not let the convenience of ordering a kit replace care you need now. CDC recommends discussing the appropriate testing with a healthcare provider, and the result should be interpreted alongside the reason you tested. 1 For continuing symptoms, see what negative vaginal tests do not settle.

The useful comparison

Choose a test that matches a clear question and gives you a useful next step. A shorter panel that covers the right infection and site is more informative for that question than a larger panel that leaves them out. Keep the label, collection date, and complete result so that follow-up is based on what was actually tested, not simply “my home test was negative.” 1 4

This is general information, not an individual testing recommendation or diagnosis. See the medical information disclaimer.

Sources

  1. CDC: Getting Tested for STIs. Updated March 17, 2026; checked September 14, 2026. Testing situations, sample sites, and the differences between home collection and testing in a clinic.
  2. FDA: Authorization of the Visby Medical Women's Sexual Health Test. March 28, 2025; checked September 14, 2026. Exact targets, specimen, device/app workflow, and result limitations.
  3. FDA: Authorization of the Simple 2 home-sample collection test. November 15, 2023; checked September 14, 2026. Age, panel, designated assay/laboratory, activation, and follow-up.
  4. FDA: How You Can Get the Best Results With Home Use Tests. Checked September 14, 2026. Label, timing, handling, limitations, and record keeping.